Use of Laboratory Balances in the Pharmaceutical Industry

Overview

Pharmaceutical regulations - including rules for testing and analyzing drugs - must be met if pharmaceutical companies want to bring their manufactured products to market. These regulations are outlined in pharmacopeias, such as the United States Pharmacopeia (USP) for the US market and the European Pharmacopoeia (Ph.Eur.) for the European market.

While the US Pharmacopeia has featured a chapter on the use of laboratory balances for several years, a respective chapter has only recently been introduced to the Ph.Eur. It became mandatory in January 2022.

This graphic summarizes lab balance regulations according to both pharmacopeias - and highlights the differences between them.

• Document type: Infographic
• Page count: 4
• Read time: 8 minutes

Complete the Form to Access Infographic